InvestSMART

Genmin Limited (ASX: GEN) - Announcements

- Current share price for GEN : $0.008

ASX company news and announcements for Genmin Limited (GEN) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Genmin Limited (GEN) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Genmin Limited (GEN), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Genmin Limited (GEN)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$28 Interim Financial Statements 2020 9 Mar 2021 11:25AM $0.008 n/a
$28 Audited Financial Statements 2019 9 Mar 2021 11:24AM $0.008 n/a
$28 Audited Financial Statements 2018 9 Mar 2021 11:23AM $0.008 n/a
$28 Constitution 9 Mar 2021 11:20AM $0.008 n/a
$28 Prospectus 9 Mar 2021 11:19AM $0.008 n/a
$28 Information Form and Checklist Annexure 1 9 Mar 2021 11:18AM $0.008 n/a
$28 Information Form and Checklist 9 Mar 2021 11:17AM $0.008 n/a
$28 Appendix 1A 9 Mar 2021 11:14AM $0.008 n/a
$28 ASX Market Release - Admission and Quotation 9 Mar 2021 11:13AM $0.008 n/a
$28 Suspension from Official Quotation 13 Nov 2012 10:28AM $0.019 $0.008 fallen by 57.89%
$28 GEN - Response to ASX Appendix 4C Query 12 Nov 2012 1:15PM $0.019 $0.008 fallen by 57.89%
$28 Trading Halt 12 Nov 2012 10:18AM $0.019 $0.008 fallen by 57.89%
$28 Appendix 4C - quarterly 24 Oct 2012 1:42PM $0.019 $0.008 fallen by 57.89%
$28 Half Yearly Report and Accounts 28 Aug 2012 1:35PM $0.030 $0.008 fallen by 73.33%
$28 Appendix 4C - quarterly 25 Jul 2012 1:35PM $0.030 $0.008 fallen by 73.33%
$28 Genesis Research Merger Proposal Terminated 18 Jul 2012 4:03PM $0.030 $0.008 fallen by 73.33%
$28 Appendix 4C - quarterly 16 Apr 2012 8:29AM $0.030 $0.008 fallen by 73.33%
$28 Preliminary Final Report 29 Feb 2012 8:25AM $0.030 $0.008 fallen by 73.33%
$28 Appendix 4C - quarterly 31 Jan 2012 8:21AM $0.030 $0.008 fallen by 73.33%
$28 Genesis to Merge with Mariposa Health 12 Jan 2012 11:36AM $0.030 $0.008 fallen by 73.33%
$28 Update re Discussions with UBNZ 18 Oct 2011 10:38AM $0.030 $0.008 fallen by 73.33%
$28 Appendix 4C - quarterly 11 Oct 2011 10:41AM $0.030 $0.008 fallen by 73.33%
$28 Reinstatement to Official Quotation 2 Sep 2011 5:54PM $0.030 $0.008 fallen by 73.33%
$28 Half Year Report 30 Aug 2011 8:24AM $0.030 $0.008 fallen by 73.33%
$28 Appendix 4C - quarterly 27 Jul 2011 8:28AM $0.030 $0.008 fallen by 73.33%

376 - 400 of 443 results

Page 16 of 18

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.